phthalocyanine has been researched along with Head and Neck Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Bruijn, HS; Farrell, E; Mashayekhi, V; Oliveira, S; Peng, W; Robinson, DJ; Roodenburg, JLN; Sioud, M; van Dam, GM; Witjes, MJH | 1 |
Gerber-Leszczyszyn, H; Marszalik, P; Ziółkowski, P | 1 |
1 review(s) available for phthalocyanine and Head and Neck Neoplasms
Article | Year |
---|---|
Photodynamic therapy of head and neck tumors and non-tumor like disorders.
Topics: Clinical Trials as Topic; Dihematoporphyrin Ether; Head and Neck Neoplasms; Hematoporphyrin Photoradiation; Humans; Indoles; Isoindoles; Light; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Porphobilinogen Synthase; Treatment Outcome | 2004 |
1 other study(ies) available for phthalocyanine and Head and Neck Neoplasms
Article | Year |
---|---|
Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines.
Topics: Antineoplastic Agents; Cell Culture Techniques; Cell Line, Tumor; Cetuximab; ErbB Receptors; Head and Neck Neoplasms; Humans; Immunotherapy; Indoles; Isoindoles; Photochemotherapy; Photosensitizing Agents | 2018 |